Page last updated: 2024-10-30

losartan and Schistosoma mansoni Infection

losartan has been researched along with Schistosoma mansoni Infection in 2 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research Excerpts

ExcerptRelevanceReference
"Schistosomiasis mansoni is involved in hepatic fibrogenesis and portal hypertension."1.48The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis. ( Augusto, MJ; Elias Júnior, J; Parreira, NA; Prado, CM; Ramalho, FS; Ramalho, LNZ; Rodrigues, V; Silva, DM, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parreira, NA1
Ramalho, FS1
Augusto, MJ1
Silva, DM1
Prado, CM1
Elias Júnior, J1
Rodrigues, V1
Ramalho, LNZ1
El-Lakkany, NM1
El-Maadawy, W1
Ain-Shoka, A1
Badawy, A1
Hammam, O1
Ebeid, F1

Other Studies

2 other studies available for losartan and Schistosoma mansoni Infection

ArticleYear
The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis.
    Experimental parasitology, 2018, Volume: 191

    Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals;

2018
Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
    Clinical and experimental pharmacology & physiology, 2011, Volume: 38, Issue:10

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anthelmintics; Disease Models, Animal; Drug Therap

2011